Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future

Authors

  • Mark E. Brecher,

    Corresponding author
    1. From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.
    Search for more papers by this author
  • Morris A. Blajchman,

    1. From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.
    Search for more papers by this author
  • Roslyn Yomtovian,

    1. From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.
    Search for more papers by this author
  • Paul Ness,

    1. From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.
    Search for more papers by this author
  • James P. AuBuchon

    1. From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.
    Search for more papers by this author

Mark E. Brecher, MD, FCAP, Chief Medical Officer, Laboratory Corporation of America, 531 South Spring Street, Burlington, NC 27215; e-mail: Mark.Brecher@LabCorp.com.

Ancillary